281 related articles for article (PubMed ID: 29190320)
1. Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort.
Chotiprasitsakul D; Han JH; Cosgrove SE; Harris AD; Lautenbach E; Conley AT; Tolomeo P; Wise J; Tamma PD;
Clin Infect Dis; 2018 Jan; 66(2):172-177. PubMed ID: 29190320
[TBL] [Abstract][Full Text] [Related]
2. Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.
Tamma PD; Conley AT; Cosgrove SE; Harris AD; Lautenbach E; Amoah J; Avdic E; Tolomeo P; Wise J; Subudhi S; Han JH;
JAMA Intern Med; 2019 Mar; 179(3):316-323. PubMed ID: 30667477
[TBL] [Abstract][Full Text] [Related]
3. Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia.
Park SH; Milstone AM; Diener-West M; Nussenblatt V; Cosgrove SE; Tamma PD
J Antimicrob Chemother; 2014 Mar; 69(3):779-85. PubMed ID: 24159153
[TBL] [Abstract][Full Text] [Related]
4. Empiric combination therapy for gram-negative bacteremia.
Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
[TBL] [Abstract][Full Text] [Related]
5. Short versus long duration antimicrobial treatment for community-onset bacteraemia: A propensity score matching study.
Lee CC; Hsieh CC; Yang CY; Hong MY; Lee CH; Tang HJ; Ko WC
Int J Antimicrob Agents; 2019 Aug; 54(2):176-183. PubMed ID: 31108223
[TBL] [Abstract][Full Text] [Related]
6. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
[TBL] [Abstract][Full Text] [Related]
7. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES
JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of short- versus prolonged-courses of antimicrobial therapy for carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A propensity score-matched cohort study.
You TY; Lo CL; Tsai WC; Jan HE; Ko WC; Lee NY
J Microbiol Immunol Infect; 2024 May; ():. PubMed ID: 38849216
[TBL] [Abstract][Full Text] [Related]
9. Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score study.
Meije Y; Pigrau C; Fernández-Hidalgo N; Clemente M; Ortega L; Sanz X; Loureiro-Amigo J; Sierra M; Ayestarán A; Morales-Cartagena A; Ribera A; Duarte A; Abelenda G; Rodríguez-Baño J; Martínez-Montauti J
Int J Antimicrob Agents; 2019 Aug; 54(2):189-196. PubMed ID: 31075401
[TBL] [Abstract][Full Text] [Related]
10. Short- versus long-course therapy in gram-negative bacilli bloodstream infections.
Sousa A; Pérez-Rodríguez MT; Suárez M; Val N; Martínez-Lamas L; Nodar A; Longueira R; Crespo M
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):851-857. PubMed ID: 30680566
[TBL] [Abstract][Full Text] [Related]
11. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
[TBL] [Abstract][Full Text] [Related]
12. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review and Meta-analysis of Antibiotic Treatment Duration for Bacteremia Due to
Tansarli GS; Andreatos N; Pliakos EE; Mylonakis E
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30803971
[TBL] [Abstract][Full Text] [Related]
14. Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
Lee NY; Lee CC; Huang WH; Tsui KC; Hsueh PR; Ko WC
Clin Infect Dis; 2013 Feb; 56(4):488-95. PubMed ID: 23090931
[TBL] [Abstract][Full Text] [Related]
15. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
16. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
von Dach E; Albrich WC; Brunel AS; Prendki V; Cuvelier C; Flury D; Gayet-Ageron A; Huttner B; Kohler P; Lemmenmeier E; McCallin S; Rossel A; Harbarth S; Kaiser L; Bochud PY; Huttner A
JAMA; 2020 Jun; 323(21):2160-2169. PubMed ID: 32484534
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period.
Folgori L; Livadiotti S; Carletti M; Bielicki J; Pontrelli G; Ciofi Degli Atti ML; Bertaina C; Lucignano B; Ranno S; Carretto E; Muraca M; Sharland M; Bernaschi P
Pediatr Infect Dis J; 2014 Sep; 33(9):929-32. PubMed ID: 24642515
[TBL] [Abstract][Full Text] [Related]
18. Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.
Yahav D; Franceschini E; Koppel F; Turjeman A; Babich T; Bitterman R; Neuberger A; Ghanem-Zoubi N; Santoro A; Eliakim-Raz N; Pertzov B; Steinmetz T; Stern A; Dickstein Y; Maroun E; Zayyad H; Bishara J; Alon D; Edel Y; Goldberg E; Venturelli C; Mussini C; Leibovici L; Paul M;
Clin Infect Dis; 2019 Sep; 69(7):1091-1098. PubMed ID: 30535100
[TBL] [Abstract][Full Text] [Related]
19. Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation.
Ranganath N; Yetmar ZA; McCandless AR; Rivera CG; Lahr BD; Tande AJ; Shah AS
Transpl Infect Dis; 2023 Oct; 25(5):e14085. PubMed ID: 37279240
[TBL] [Abstract][Full Text] [Related]
20. 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial.
Daneman N; Rishu AH; Pinto R; Aslanian P; Bagshaw SM; Carignan A; Charbonney E; Coburn B; Cook DJ; Detsky ME; Dodek P; Hall R; Kumar A; Lamontagne F; Lauzier F; Marshall JC; Martin CM; McIntyre L; Muscedere J; Reynolds S; Sligl W; Stelfox HT; Wilcox ME; Fowler RA;
Trials; 2018 Feb; 19(1):111. PubMed ID: 29452598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
